Heidrun Potschka
Oncology · 2005–2020
A researcher in the Science corpus: 4 papers; trusts 4 researchers and is trusted by 3 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 43 citations into it; #702 of 1,698 by trust here, #1,162 by citations
- Pediatrics, Perinatology and Child Health — 28 citations into it; #267 of 722 by trust here, #314 by citations
- Psychiatry and Mental health — 20 citations into it
- Cellular and Molecular Neuroscience — 14 citations into it
- Neurology — 9 citations into it
Whom Heidrun Potschka trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Heidrun Potschka overall
Papers from Heidrun Potschka's perspective
Ordered by how strongly the researchers Heidrun Potschka trusts endorse each paper. Same corpus, a different order for every researcher.
- Drug-resistant epilepsy. (New England Journal of Medicine)
- CSF1 receptor signaling is necessary for microglia viability, which unmasks a cell that rapidly repopulates the microglia-depleted adult brain (Neuron)
- Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs: A 30-Year Longitudinal Cohort Study (JAMA Neurology)
- The gut microbiota mediates the anti-seizure effects of the ketogenic diet (Cell)
- Neuronal activity modifies DNA methylation landscape in the adult brain (Nature Neuroscience)
- Interleukin-1β Enhances NMDA Receptor-Mediated Intracellular Calcium Increase through Activation of the Src Family of Kinases (Journal of Neuroscience)
- Blood-brain barrier tight junction permeability and ischemic stroke. (Neurobiology of Disease)
- Blood–brain barrier structure and function and the challenges for CNS drug delivery
- Environmental standardization: cure or cause of poor reproducibility in animal experiments? (Nature Methods)
- New avenues for anti-epileptic drug discovery and development (Nature reviews. Drug discovery)
Their papers
- Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options (2020) — 780 citations
- Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases. (2005) — 613 citations
- Drug resistance in brain diseases and the role of drug efflux transporters (2005) — 908 citations
- Blood-brain barrier active efflux transporters: ATP-binding cassette gene family (2005) — 682 citations